ContactPrint • DisclaimerPrivacy PolicyTerms & Conditions

Recent Publications


  • Cappable-seq Service now available !

    In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).

    It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).

vertis Biotechnologie AG
Lise-Meitner-Str. 30
D-85354 Freising

Fon +49-(0)8161-18516-11
Fax +49-(0)8161-18516-12

Contact FormHow to find us

Dear Visitor, 

we welcome you on the website of vertis Biotechnologie AG. We are a research-oriented company in the field of functional genomics. The strength of our service is customer-oriented flexibility which is based on our innovative technology platform which we have developed in our 16-year history.

We offer innovative tools and strategies for the comprehensive qualitative and quantitative analysis of bacterial and eukaryotic transcriptomes, using state-of-the-art Next Generation Sequencing (NGS) of RNA molecules (RNA-seq). 

Special emphasis of VERTIS lies in the analysis of bacterial transcriptomes. We are able to provide specialised applications like dRNA-seq, tagRNA-seq, dual RNA-seq, Cappable-seq, etc., to our customers.

Our consequent use of a robotic system for NGS library preparation guarantees highly reproducible data, more consistent yields and higher quality data.

We offer a complete product line, ranging from project consulting, nucleic acid isolation, NGS library preparation, DNA sequencing to bioinformatic sequence analysis and data mining.


Our services cover the following areas: